Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,767 public trials 879 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Active, not recruiting

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

NCT05639114

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Llc Anniston, Alabama, United States
  • Providence Medical Center Burbank, California, United States
  • University of California San Diego La Jolla, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 135 locations
View Trial Details
Active, not recruiting

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT05126277

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California Irvine Orange, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 147 locations
View Trial Details
Active, not recruiting

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

NCT06331312

Conditions
Connective Tissue Diseases, Muscular Diseases, Musculoskeletal Diseases, +3 more
Locations
  • Arizona Arthritis and Rheumatology Associates PLLC Avondale, Arizona, United States
  • Sun Valley Arthritis Center Ltd Peoria, Arizona, United States
  • Millennium Clinical Trials Westlake Village, California, United States
  • Rheumatology Associates of South Florida Boca Raton, Florida, United States
View all 85 locations
View Trial Details
Active, not recruiting

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

NCT05624749

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California LA Los Angeles, California, United States
  • Homestead Assoc In Research Inc Homestead, Florida, United States
View all 90 locations
View Trial Details
Active, not recruiting

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

NCT05798117

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Pessac, France
  • Novartis Investigative Site Strasbourg, France
View Trial Details
Active, not recruiting

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

NCT05531565

Conditions
Autoimmune Diseases, Chronic Cutaneous Lupus Erythematosus, Connective Tissue Diseases, +7 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • UAB Center for Women's Reproductive Health Birmingham, Alabama, United States
  • Arizona Arthritis & Rheumatology Research, PLLC Phoenix, Arizona, United States
  • The Regents of the University of California La Jolla, California, United States
View all 315 locations
View Trial Details
Active, not recruiting

Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)

NCT04179032

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Rosario, Argentina
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site Saint Augustin, Germany
View Trial Details
Active, not recruiting

A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.

NCT05985915

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Advanced Medical Research La Palma, California, United States
  • Medvin Clinical Research Van Nuys, California, United States
  • Bay Area Arthritis And Osteoporosis Brandon, Florida, United States
View all 198 locations
View Trial Details
Active, not recruiting

Long-term Follow-Up for RGX-121

NCT04597385

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +22 more
Locations
  • University of California, San Francisco (UCSF)- Benioff Children's Hospital San Francisco, California, United States
  • Saint Peter's Healthcare System New Brunswich, New Jersey, United States
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
View Trial Details

Related conditions